Department of Rehabilitation Sciences, Neurorehabilitation Research Group (eNRGy), KU Leuven, Tervuursevest 101, bus 1501, B-3001, Leuven, Belgium.
Institut Guttmann, Institut Universitari de Neurorehabilitació Adscrit a la UAB, Badalona, Barcelona, Spain.
J Neural Transm (Vienna). 2022 Apr;129(4):379-386. doi: 10.1007/s00702-022-02493-6. Epub 2022 Mar 31.
Motor control of automatized and overlearned sequences, such as writing, is affected in Parkinson's disease (PD), impacting patients' daily life. Medication effects on motor performance are not only task-specific, but also variable within tasks. The nature of this variance is still unclear. This study aimed to investigate whether medication affects writing sequences differently when producing up- or downstrokes. Writing was assessed in healthy controls (HC) (N = 31) and PD (N = 32), when ON and OFF medication in a randomized order (interspersed by two months). Subjects wrote a sequential pattern with an increasing size on a digital tablet. Writing outcomes were movement vigor (amplitude and velocity), error and end-point variability, and sequence continuation, calculated separately for up- and downstrokes. Results showed that PD patients OFF-medication reduced movement vigor (amplitude) for up- and downstrokes compared to HC. Clear deficits were found for up- but not for downstroke error in PD patients in OFF, suggesting a directional bias. Dopaminergic medication improved motor vigor by increasing writing amplitude and upstroke continuation, but this occurred at the cost of the downstroke trajectory. Other writing outcomes did not improve with medication intake. In conclusion, we interpret these findings as that the impact of dopamine is complex, highly task-specific, supporting the most highly energy demanding components of a writing sequence. As medication did not regulate downstroke writing, we recommend supplementary training to address task demands that were less modulated by dopamine (registration: https://osf.io/gk5q8/ , 17 July 2018).
自动和过度学习序列的运动控制,如书写,在帕金森病(PD)中受到影响,影响患者的日常生活。药物对运动表现的影响不仅是特定于任务的,而且在任务内也是可变的。这种变化的性质尚不清楚。本研究旨在探讨药物是否会以不同的方式影响书写序列中的上行和下行笔画。在药物治疗(ON)和非药物治疗(OFF)状态下,分别对 31 名健康对照者(HC)和 32 名帕金森病患者进行了书写评估,以随机顺序(间隔两个月)进行。受试者在数字平板电脑上书写一个递增大小的序列。分别对上行和下行笔画计算书写结果,包括运动活力(幅度和速度)、错误和终点变异性以及序列延续性。结果表明,与 HC 相比,PD 患者 OFF 药物治疗时减少了上行和下行笔画的运动活力(幅度)。PD 患者 OFF 药物治疗时,上行笔画的错误明显减少,但下行笔画的错误则没有,这表明存在定向偏差。多巴胺能药物通过增加书写幅度和上行笔画的延续性来改善运动活力,但这是以牺牲下行笔画轨迹为代价的。其他书写结果并没有随着药物的摄入而改善。总之,我们将这些发现解释为多巴胺的影响是复杂的,高度任务特异性的,支持书写序列中能量需求最高的成分。由于药物治疗不能调节下行笔画的书写,我们建议进行补充训练,以满足那些较少受到多巴胺调节的任务需求(注册:https://osf.io/gk5q8/ ,2018 年 7 月 17 日)。